Cambridge, United Kingdom

Neil Fraser

This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neil Fraser. Retrieved from https://idiyas.com/inventor/neil-fraser-98ked4hk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Neil Fraser: Innovator in Pharmaceutical Chemistry

Introduction

Neil Fraser is a distinguished inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his work on galanthamine derivatives. His innovative approach has led to the development of valuable processes in drug preparation.

Latest Patents

Neil Fraser holds a patent for "Galanthamine derivatives and process for their preparation." This patent highlights his expertise in creating compounds that have potential therapeutic applications. He has a total of 1 patent to his name, showcasing his focused contributions to the industry.

Career Highlights

Neil Fraser is currently employed at Janssen Pharmaceutica NV, a leading company in the pharmaceutical sector. His role at Janssen allows him to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative drug solutions.

Collaborations

Throughout his career, Neil has collaborated with notable colleagues, including David Andrew Chaplin and Peter David Tiffin. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Neil Fraser's work in pharmaceutical chemistry exemplifies the importance of innovation in drug development. His contributions, particularly in galanthamine derivatives, reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…